During the past decade, The Angeles Clinic and Research Institute conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 35 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 18 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Angeles Clinic and Research Institute" #1 sponsor was "Bristol-Myers Squibb" with 20 trials, followed by "Incyte Corporation" with 8 trials sponsored, "Immunocore Ltd" with 5 trials sponsored, "Incyte Biosciences International Sàrl" with 4 trials sponsored and "Novartis Pharmaceuticals" with 4 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Angeles Clinic and Research Institute" #1 collaborator was "Merck Sharp & Dohme LLC" with 7 trials as a collaborator, "Medarex" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Sanofi" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "The Angeles Clinic and Research Institute" are "Melanoma" (37 trials), "Metastatic Melanoma" (10 trials), "Advanced Malignancies" (7 trials), "Breast Cancer" (6 trials) and "Head and Neck Cancer" (6 trials). Many other conditions were trialed in "The Angeles Clinic and Research Institute" in a lesser frequency.

Most popular intervention types in "The Angeles Clinic and Research Institute" are "Drug" (95 trials), "Biological" (30 trials), "Radiation" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (17 trials), "Pembrolizumab" (11 trials), "Nivolumab" (10 trials), "Atezolizumab" (6 trials) and "Placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "The Angeles Clinic and Research Institute" are 113 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Angeles Clinic and Research Institute". undefined are not yet recruiting, 22 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in The Angeles Clinic and Research Institute, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in The Angeles Clinic and Research Institute, 64 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".